Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types

Experimental Biology and Medicine

Volumn 232, Issue 10, 2007, Pages 1368-1380

  Rodriguez, Ryan T ^a,d   Velkey, J Matthew ^b   Lutzko, Carolyn ^c   Seerke, Rina ^a   Kohn, Donald B ^c   O'Shea, K Sue ^b   Firpo, Meri T ^a,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f NONE   (United States)

Author keywords

Differentiation; Knockdown; Overexpression; Self renewal; Stem cell

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; OCTAMER TRANSCRIPTION FACTOR 4; PLASMID VECTOR;

ARTICLE; CELL DIFFERENTIATION; CELL TYPE; DNA SEQUENCE; DOWN REGULATION; EMBRYONIC STEM CELL; ENDODERM; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MESODERM; MOLECULAR CLONING; RNA INTERFERENCE; UPREGULATION;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; ELECTROPORATION; EMBRYONIC STEM CELLS; GENES, REPORTER; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION;

MUS;

EID: 35549000259     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0703-RM-63     Document Type: Article

References (47)

1. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391, 1998.
2. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376, 2000.
3. Palmieri SL, Peter W, Hess H, Scholer HR. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 166:259-267, 1994.
4. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 6:999-1004, 2000.
5. Velkey JM, O'Shea KS. Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells. Genesis 37:18-24, 2003.
6. Hay DC, Sutherland L, Clark J, Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22:225-235, 2004.
7. Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, Moore HD, Andrews PW. Specific knockdown of Oct4 and beta 2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22:659-668, 2004.
8. Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11:514-518, 2001.
9. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271-278, 2000.
10. Pikaart MJ, Recillas-Targa F, Felsenfeld G. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev 12:2852-2862, 1998.
11. Pannell D, Ellis J. Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol 11:205-217, 2001.
12. Chen S, Corces VG. The gypsy insulator of Drosophila affects chromatin structure in a directional manner. Genetics 159:1649-1658, 2001.
13. Bestor TH. Gene silencing as a threat to the success of gene therapy. J Clin Invest 105, 409-411, 2003.
14. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21:111-117, 2000.
15. Haas DL, Case SS, Crooks GM, Kohn DB. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther 2:71-80, 2000.
16. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 99:5515-5520, 2002.
17. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A 99:6047-6052, 2002.
18. Kim MH, Yuan X, Okumura S, Ishikawa F. Successful inactivation of endogenous Oct-3/4 and c-mos genes in mouse preimplantation embryos and oocytes using short interfering RNAs. Biochem Biophys Res Commun 296:1372-1377, 2002.
19. Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 21:559-561, 2003.
20. Anneren C, Cowan CA, Melton DA. The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. J Biol Chem 279:31590-31598, 2004.
21. Vallier L, Rugg-Gunn PJ, Bouhon IA, Andersson FK, Sadler AJ, Pedersen RA. Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells 22:2-11, 2004.
22. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19:271-278, 2001.
23. Pesce M, Scholer HR. Oct-4: control of totipotency and germline determination. Mol Reprod Dev 55:452-457, 2000.
24. Guo Y, Costa R, Ramsey H, Starnes T, Vance G, Robertson K, Kelley M, Reinbold R, Scholer H, Hromas R. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci U S A 99:3663-3667, 2002.
25. Levinson-Dushnik M, Benvenisty N. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells. Mol Cell Biol 17:3817-3822, 1997.
26. Thomassin H, Bois-Joyeux B, Delille R, Ikonomova R, Danan JL. Chicken ovalbumin upstream promoter-transcription factor, hepatocyte nuclear factor 3, and CCAAT/enhancer binding protein control the far-upstream enhancer of the rat alpha-fetoprotein gene. DNA Cell Biol 15:1063-1074, 1996.
27. Niwa H, Masui S, Chambers I, Smith AG, Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol Cell Biol 22:1526-1536, 2002.
28. Meno C, Gritsman K, Ohishi S, Ohfuji Y, Heckscher E, Mochida K, Shimono A, Kondoh H, Talbot WS, Robertson EJ, Schier AF, Hamada H. Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. Mol Cell 4:287-298, 1999.
29. Bisgrove BW, Essner JJ, Yost HJ. Regulation of midline development by antagonism of lefty and nodal signaling. Development 126:3253-3262, 1999.
30. Meno C, Takeuchi J, Sakuma R, Koshiba-Takeuchi K, Ohishi S, Saijoh Y, Miyazaki J, ten Dijke P, Ogura T, Hamada H. Diffusion of nodal signaling activity in the absence of the feedback inhibitor Lefty2. Dev Cell 1:127-138, 2001.
31. Sakuma R, Ohnishi Yi Y, Meno C, Fujii H, Juan H, Takeuchi J, Ogura T, Li E, Miyazono K, Hamada H. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 7:401-412, 2002.
32. Russ AP, Wattler S, Colledge WH, Aparicio SA, Carlton MB, Pearce JJ, Barton SC, Surani MA, Ryan K, Nehls MC, Wilson V, Evans MJ. Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature 404:95-99, 2000.
33. Botquin V, Hess H, Fuhrmann G, Anastassiadis C, Gross MK, Vriend G, Scholer HR. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev 12:2073-2090, 1998.
34. Tomilin A, Remenyi A, Lins K, Bak H, Leidel S, Vriend G, Wilmanns M, Scholer HR. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell 103:853-864, 2000.
35. Reim G, Mizoguchi T, Stainier DY, Kikuchi Y, Brand M. The POU domain protein spg (pou2/Oct4) is essential for endoderm formation in cooperation with the HMG domain protein casanova. Dev Cell 6:91-101, 2004.
36. Lunde K, Belting HG, Driever W. Zebrafish pou5f1/pou2, homolog of mammalian Oct4, functions in the endoderm specification cascade. Curr Biol 14:48-55, 2004.
37. Asche W, Colletta G, Warnecke G, Nobis P, Pennie S, King RM, Ostertag W. Lack of retrovirus gene expression in somatic cell hybrids of friend cells and teratocarcinoma cells with a teratocarcinoma phenotype. Mol Cell Biol 4:923-930, 1984.
38. Challita PM, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A 91:2567-2571, 1994.
39. Zahres H, Lensch W, Daheron L, Stewart S, Itskovitch-Eldor J, Daley G. High-efficiency interference in human embryonic stem cells. Stem Cells 23:299-305, 2005.
40. Ciruna BG, Rossant J. Expression of the T-box gene Eomesodermin during early mouse development. Mech Dev 81:199-203, 1999.
41. Hancock SN, Agulnik SI, Silver LM, Papaioannou VE. Mapping and expression analysis of the mouse ortholog of Xenopus Eomesodermin. Mech Dev 81:205-208, 1999.
42. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548-2556, 2000.
43. Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 18:4261-4269, 1999.
44. Nakamura T, Arai T, Takagi M, Sawada T, Matsuda T, Yokota T, Heike T. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors. Biochem Biophys Res Commun 248:22-27, 1998.
45. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12:2048-2060, 1998.
46. Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo MT, Rose-John S, Hayek A. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22:522-530, 2004.
47. Tarantal AF, O'Rourke JP, Case SS, Newbound GC, Li J, Lee CI, Baskin CR, Kohn DB and Bunnell BA. Rhesus monkey model for fetal gene transfer: studies with retroviral-based vector systems. Mol Ther 3:128-138, 2001.